INCIDENCE OF AND RISK FACTORS FOR CHILDHOOD THROMBOSIS: A Single-Center Experience in Ankara, Turkey

REFERENCES

• Monagle P, Andrew M. Acquired disorders of hemostasis. Nathan and Oski's Hematology of Infancy and Childhood 6th, Nathan DG, Orkin SH, Ginsburg D, Look AT. Saunders, Philadelphia, PA 2003; 1631–1667
   Google Scholar
• KA Bauer. Inherited disorders of thrombosis and fibrinolysis. Nathan and Oski's Hematology of Infancy and Childhood 6th, DG Nathan, SH Orkin, D Ginsburg, AT Look. Saunders, Philadelphia, PA 2003; 1583–96
   Google Scholar
• Nowak-Gottl U, Duering C, Kempf-Bielack B, Strater R. Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb 2003/2004; 33: 269–274
   PubMedGoogle Scholar
• Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian Registry of VTE. Blood 1994; 83: 1251–1257
   PubMed Web of Science ®Google Scholar
• van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: A prospective two-year registry in The Netherlands. J Pediatr 2001; 139: 676–681
   PubMed Web of Science ®Google Scholar
• Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763–766
   PubMed Web of Science ®Google Scholar
• Oren H, Devecioglu O, Ertem M, et al. Analysis of pediatric thrombotic patients in Turkey. Pediatr Hematol Oncol 2004; 21: 573–583
   PubMed Web of Science ®Google Scholar
• Carter C, Gent M. The epidemiology of venous thrombosis. Hemostasis and Thrombosis. Basic Principles and Clinical Practice, R Colman, J Hirsh, V Marder, E Salzman. JB Lippincott, Philadelphia, PA 1982; 805–819
   Google Scholar
• Ehrenforth S, Junker R, Koch HG, et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Childhood Thrombophilia Study Group. Eur J Pediatr. 1999; 158(Suppl 3)S97–S104
   PubMedGoogle Scholar
• Nowak-Gottl U, Wermes C, Junker R, et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999; 93: 1595–1599
   PubMed Web of Science ®Google Scholar
• Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: A report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763–766
   PubMed Web of Science ®Google Scholar
• Alioglu B, Atac B, Baskin E, Ozbek N. Deep vein thrombosis in a child with down syndrome: A case study. Turk J Hematol, In press
   Google Scholar
• Segel GB, Francis CA. Anticoagulant proteins in childhood venous and arterial thrombosis: A review. Blood Cells Mol Dis 2000; 26: 540–60
   PubMed Web of Science ®Google Scholar
• Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95: 1517–1532
   PubMed Web of Science ®Google Scholar
• Alioglu B, Ozyurek E, Tarcan A, Atac FB, Gurakan B, Ozbek N. Heterozygous methylene-tetrahydrofolate reductase 677C-T gene mutation with mild hyperhomocysteinemia associated with intrauterine iliofemoral artery thrombosis. Blood Coagul Fibrinolysis 2006; 17: 495–498
   Google Scholar
• Alioglu B, Avci Z, Aytekin C, et al. Budd-Chiari syndrome in a child due to a membranous web of the inferior vena cava resolved by systemic and local recombinant tissue plasminogen activator treatment. Blood Coagul Fibrinolysis 2006; 17: 209–212
   PubMed Web of Science ®Google Scholar
• Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A 1993, 90: 1004–1008
   Google Scholar
• Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517–522
   PubMed Web of Science ®Google Scholar
• Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–67
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113
   PubMed Web of Science ®Google Scholar
• Kluijtmans LA, Wendel U, Stevens EM, van den Heuvel LP, Trijbels FJ, Blom HJ. Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet 1998; 6: 257–265
   Google Scholar
• Brugnara C. Reference values in infancy and childhood. Nathan and Oski's Hematology of Infancy and Childhood 6th, DG Nathan, SH Orkin, D Ginsburg, AT Look. Saunders, Philadelphia, PA 2003; 1835–1864
   Google Scholar
• Akar N, Akar E, Akcay R, Avcu F, Yalcin A, Cin S. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res 2000; 97: 163–167
   PubMedGoogle Scholar
• De Stefano V, Zappacosta B, Persichilli S, et al. Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease. Br J Haematol 1999; 106: 564–568
   PubMedGoogle Scholar
• Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb Haemost 1990; 63: 27–30
   PubMed Web of Science ®Google Scholar
• Ling X, Delorme M, Berry L, et al. Alpha 2-macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces. Pediatr Res 1995; 37: 373–378
   Google Scholar
• Mitchell L, Piovella F, Ofosu F, Andrew M. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood 1991; 78: 2299–2304
   Google Scholar
• Price V, Massicotte MP. Arterial thromboembolism in the pediatric population. Semin Thromb Hemost 2003; 29: 557–565
   Google Scholar
• Schmidt B, Andrew M. Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics 1995; 96(5 Pt 1)939–943
   PubMed Web of Science ®Google Scholar
• Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: Two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: F163–F167
   PubMed Web of Science ®Google Scholar
• Gurgey A, Tekinalp G, Cinar A, Cakmak F. Symptomatic thrombosis in Turkish neonates. J Pediatr Hematol Oncol 2004; 26: 417–420
   PubMedGoogle Scholar
• Coon PD, Rychik J, Novello RT, Ro PS, Gaynor JW, Spray TL. Thrombus formation after the Fontan operation. Ann Thorac Surg 2001; 71: 1990–1994
   Google Scholar
• Ozbek N, Atac FB, Yildirim SV, et al. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery. Cardiol Young 2005; 15: 19–25
   Google Scholar
• Kocis KC, Snider AR, Vermilion RP, Beekman RH. Two-dimensional and Doppler ultrasound evaluation of femoral arteries in infants after cardiac catheterization. Am J Cardiol 1995; 75: 642–645
   PubMed Web of Science ®Google Scholar
• Vitiello R, McCrindle BW, Nykanen D, Freedom RM, Benson LN. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol 1998; 32: 1433–40
   PubMed Web of Science ®Google Scholar
• Saxena A, Gupta R, Kumar RK, Kothari SS, Wasir HS. Predictors of arterial thrombosis after diagnostic cardiac catheterization in infants and children randomized to two heparin dosages. Cathet Cardiovasc Diagn 1997; 41: 400–403
   PubMedGoogle Scholar
• Nowak-Gottl U, Dubbers A, Kececioglu D, et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: A prospective study. J Pediatr 1997; 131: 608–612
   PubMed Web of Science ®Google Scholar
• Nowak-Gottl U, Junker R, Hartmeier M, et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100: 743–748
   PubMed Web of Science ®Google Scholar
• Nowak-Gottl U, Kosch A, Schlegel N, Salem M, Manco-Johnson M. Thromboembolism in children. Curr Opin Hematol 2002; 9: 448–453
   PubMed Web of Science ®Google Scholar
• Nowak-Gottl U, Debus O, Findeisen M, et al. Lipoprotein (a): Its role in childhood thromboembolism. Pediatrics 1997; 99: E11
   Google Scholar
• Nowak-Gottl U, Strater R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94: 3678–3682
   PubMed Web of Science ®Google Scholar
• von Depka M, Nowak-Gottl U, Eisert R, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96: 3364–3368
   PubMed Web of Science ®Google Scholar
• Kluijtmans LA, Van Den Heuvel LP, Boers GH, et al. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 1996; 58: 35–41
   PubMed Web of Science ®Google Scholar
• Kelly PJ, Rosand J, Kistler JP, et al. Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 2002; 59: 529–536
   PubMed Web of Science ®Google Scholar
• Queffeulou G, Michel C, Vrtovsnik F, Philit JB, Dupuis E, Mignon F. Hyperhomocysteinemia, low folate status, homozygous C677T mutation of the methylene tetrahydrofolate reductase and renal arterial thrombosis. Clin Nephrol 2002; 57: 158–162
   Google Scholar
• Keijzer MB, den Heijer M, Blom HJ, et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 2002; 88: 723–728
   PubMed Web of Science ®Google Scholar
• Li XM, Wei YF, Hao HL, et al. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome. Am J Hematol 2002; 71: 11–14
   PubMed Web of Science ®Google Scholar
• Junker R, Koch HG, Auberger K, Munchow N, Ehrenforth S, Nowak-Gottl U. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999; 19: 2568–2572
   PubMed Web of Science ®Google Scholar
• Nowak-Gottl U, Junker R, Kreuz W, et al. Childhood Thrombophilia Study Group. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97: 858–862
   PubMed Web of Science ®Google Scholar
• Akar N, Akar E, Misirlioglu M, Avcu F, Yalcin A, Cin S. Search for genetic factors favoring thrombosis in Turkish population. Thromb Res 1998; 92: 79–82
   PubMed Web of Science ®Google Scholar
• Gurgey A, Balta G, Gumruk F, Altay C. Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis. Blood Coagul Fibrinolysis 2004; 15: 657–662
   Google Scholar
• Schobess R, Junker R, Auberger K, Munchow N, Burdach S, Nowak-Gottl U. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis—Evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation. Eur J Pediatr 1999; 158(Suppl 3)S105–S108
   Google Scholar
• Gurgey A, Mesci L. The prevalence of factor V Leiden (1691 G→A) mutation in Turkey. Turk J Pediatr 1997; 39: 313–315
   PubMedGoogle Scholar
• Akar N, Akar E, Dalgin G, Sozuoz A, Omurlu K, Cin S. Frequency of factor V (1691 G→ A) mutation in Turkish population. Thromb Haemost 1997; 78: 1527–1528
   PubMedGoogle Scholar
• Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346(8983)1133–1134
   PubMed Web of Science ®Google Scholar
• Gurgey A, Hicsonmez G, Parlak H, Balta G, Celiker A. Prothrombin gene 20210 G-A mutation in Turkish patients with thrombosis. Am J Hematol 1998; 59: 179–180
   PubMed Web of Science ®Google Scholar
• Gurgey A, Unal S, Okur H, Duru F, Gumruk F. Prothrombin G20210A mutation in Turkish children with thrombosis and the frequency of prothrombin C20209T. Pediatr Hematol Oncol 2005; 22: 309–314, Erratum in: Pediatr Hematol Oncol. 2005;22:541–542
   PubMed Web of Science ®Google Scholar
• Akar N, Misirlioglu M, Akar E, Avcu F, Yalcin A, Sozuoz A. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 1998; 58: 249
   PubMedGoogle Scholar